Strikingly, among the 14 ATLL patients with a TET2 mutation, 9 had a recurrent mono allelic nucleotide variation at position c.3595-4G > A (Chr.4: 106164642-106164867) (Table 1). Here, TET2 is linked to adult T-cell leukemia/lymphoma.